ClassID:

21647

A61K2300/00 - page 79 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#23401
20050272772
2005-12-08

Pharmaceutical compositions for the treatment of pruritus

#23402
20050272760
2005-12-08

Use of pyridoindolone derivatives for the preparation of medicinal products

#23403
20050272758
2005-12-08

Antineoplastic combinations of CCI-779 and rituximab

#23404
20050272755
2005-12-08

Method for treating abnormal cell growth

#23405
20050272738
2005-12-08

Combined treatment with oxaliplatin and an epidermal growth factor receptor kinase inhibitor

#23406
20050272737
2005-12-08

Combined treatment with irinotecan and an epidermal growth factor receptor kinase inhibitor

#23407
20050272719
2005-12-08

Method for inhibiting detrusor muscle overactivity

#23408
20050272717
2005-12-08

Treatment of aromatase inhibitor therapy-related osteoporosis

#23409
20050272712
2005-12-08

Compositions and methods for treatment of premenstrual dysphoric disorder

#23410
20050272707
2005-12-08

Method for preventing or reducing secondary fractures after hip fracture

#23411
20050272698
2005-12-08

Liquid stable composition of oxazaphosphorine with mesna

#23412
20050272694
2005-12-08

Composition containing beta-glucan and constipation-relieving drug, immunopotentiatior, and skin moistening agent using the composition

#23413
20050272690
2005-12-08

Compositions and methods for sleep regulation

#23414
20050272689
2005-12-08

Methods, compositions, and kits for organ protection during systemic anticancer therapy

#23415
20050272688
2005-12-08

Combined treatment with gemcitabine and an epidermal growth factor receptor kinase inhibitor

#23416
20050272687
2005-12-08

Stable S-adenosyl-l-methionine

#23417
20050272686
2005-12-08

Nucleotide based medicament and method of use for treatment of conditions in humans

#23418
20050272676
2005-12-08

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

#23419
20050272673
2005-12-08

Pharmaceutical combination and method for treatment of reactive arthritis or bursitis

#23420
20050272669
2005-12-08

Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof

#23421
20050272663
2005-12-08

Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease

#23422
20050272655
2005-12-08

Methods of using IL-1 antagonists to treat autoinflammatory disease

#23423
20050272654
2005-12-08

NF-kappaB activation inhibitors, and their pharmaceutical uses

#23424
20050272651
2005-12-08

Methods for treating breast cancer using NRIF3 related molecules

#23425
20050272649
2005-12-08

Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure

#23426
20050272642
2005-12-08

Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog

#23427
20050272641
2005-12-08

Therapeutic agents for diabetes

#23428
20050272639
2005-12-08

Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate

#23429
20050272637
2005-12-08

Compositions and methods for modulating signaling mediated by IGF-1 receptor and erbB receptors

#23430
20050272636
2005-12-08

Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-gamma

#23431
20050272634
2005-12-08

Use of erythropoietin

#23432
20050272163
2005-12-08

Method for producing purified hematinic iron-saccharidic complex and product produced

#23433
20050272161
2005-12-08

Delivery of compounds with rehydrated blood cells

#23434
20050271779
2005-12-08

Microbiological control in poultry processing

#23435
20050271758
2005-12-08

Topical compositions containing extracellular products and uses thereof

#23436
20050271757
2005-12-08

External composition comprising an aqueous extract of red vine leaves and an anti-inflammatory agent

#23437
20050271754
2005-12-08

Composition for prevention or treatment of an alcohol hangover

#23438
20050271752
2005-12-08

Antifungal products and method of use

#23439
20050271749
2005-12-08

Electrolyte purgative

#23440
20050271747
2005-12-08

Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor

#23441
20050271746
2005-12-08

Topical treatments for abnormal biological conditions and method of topically treating such conditions

#23442
20050271744
2005-12-08

Nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction

#23443
20050271743
2005-12-08

Treatment of inflammatory skin conditions

#23444
20050271739
2005-12-08

Methods and compositions for accelerating alcohol metabolism

#23445
20050271726
2005-12-08

Immune enhancing compositions and methods of use thereof

#23446
20050271717
2005-12-08

Pharmaceutical compositions of atorvastatin

#23447
20050271716
2005-12-08

Preparation containing basic drug

#23448
20050271697
2005-12-08

Local delivery of growth factors for stem cell transplantation

#23449
20050271669
2005-12-08

Combinations comprising epothilones and pharmaceutical uses thereof

#23450
20050271664
2005-12-08

Antibodies for inhibiting blood coagulation and methods of use thereof

#23451
20050271661
2005-12-08

Methods and reagents for the treatment of immunoinflammatory disorders

#23452
20050271649
2005-12-08

Therapeutic adjuvant

#23453
20050271646
2005-12-08

Fibrin material and method for producing and using the same

#23454
20050271645
2005-12-08

Intratracheal administration of lysozyme with other therapeutic agents in the prevention and treatment of respiratory disorders

#23455
20050271643
2005-12-08

Bacterial strains, compositions including same and probiotic use thereof

#23456
20050271640
2005-12-08

Method for inhibiting yeast growth

#23457
20050271639
2005-12-08

Genetically engineered cells for therapeutic applications

#23458
20050271631
2005-12-08

Material compositions and related systems and methods for treating cardiac conditions

#23459
20050271626
2005-12-08

Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway

#23460
20050271622
2005-12-08

Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof

#23461
20050271618
2005-12-08

Methods of reducing aggregation of IL-1ra

#23462
20050271603
2005-12-08

Compositions comprising lactoferrin

#23463
20050271600
2005-12-08

Fiber supplement

#23464
20050271596
2005-12-08

Vasoactive kit and composition and uses thereof

#23465
20050271587
2005-12-08

Alpha-fetoprotein peptides and uses thereof

#23466
20050267215
2005-12-01

ABCA-1 elevating compounds

#23467
20050267212
2005-12-01

Omega-3 fatty acids in the treatment of depression

#23468
20050267211
2005-12-01

Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense

#23469
20050267209
2005-12-01

Mixed co-crystals and pharmaceutical compositions comprising the same

#23470
20050267206
2005-12-01

Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders

#23471
20050267204
2005-12-01

Synergistic gold-containing compositions

#23472
20050267201
2005-12-01

Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same

#23473
20050267197
2005-12-01

Compositions containing policosanol and HMG-Co-A reductase inhibitor and their pharmaceutical uses

#23474
20050267176
2005-12-01

Dopamine-agonist combination therapy for improving sleep quality

#23475
20050267144
2005-12-01

Methods of stimulating immune response in virally infected individuals

#23476
20050267140
2005-12-01

Method for treating abnormal cell growth

#23477
20050267135
2005-12-01

Combinations comprising antimuscarinic agents and PDE4 inhibitors

#23478
20050267134
2005-12-01

Non-nucleotide composition and method for inhibiting platelet aggregation

#23479
20050267127
2005-12-01

Guanidino phenylalanin compounds used as urokinase inhibitors

#23480
20050267124
2005-12-01

Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors

#23481
20050267117
2005-12-01

Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin

#23482
20050267103
2005-12-01

Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders

#23483
20050267091
2005-12-01

Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses

#23484
20050267085
2005-12-01

Combined therapy for the treatment of parkinson's disease

#23485
20050267084
2005-12-01

Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate

#23486
20050267082
2005-12-01

Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate

#23487
20050267081
2005-12-01

Use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation

#23488
20050267080
2005-12-01

Methods and related compositions for reduction of fat

#23489
20050267078
2005-12-01

Combinations comprising antimuscarinic agents and beta-adrenergic agonists

#23490
20050267077
2005-12-01

Method for improving cognitive function by co-administration of a GABAB receptor antagonist and an acetylcholinesterase inhibitor

#23491
20050267076
2005-12-01

Method for improving cognitive function

#23492
20050267072
2005-12-01

Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction

#23493
20050267069
2005-12-01

Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease

#23494
20050267052
2005-12-01

Epicatechin for hypertension treatment

#23495
20050267045
2005-12-01

Method for preparing peritoneal dialysate

#23496
20050267037
2005-12-01

Methods and compositions for treating cancer using proteasome inhibitors

#23497
20050267033
2005-12-01

Multi-dose erythropoietin formulations

#23498
20050267027
2005-12-01

Use of erythropoietin for treatment of cancer

#23499
20050267014
2005-12-01

Pharmaceutical composition comprising factor VII polypeptides and tranexamic acid

#23500
20050267013
2005-12-01

Methods for affecting various diseases utilizing LXR compounds

#23501
20050267009
2005-12-01

Method of Treatment of Acute and Persistent Pain

#23502
20050266107
2005-12-01

Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer

#23503
20050266105
2005-12-01

Compositions comprising natural agents for the treatment of HIV-associated opportunistic infections and complications and methods for preparing and using compositions comprising natural agents

#23504
20050266104
2005-12-01

Efficient method for producing compositions enriched in total phenols

#23505
20050266103
2005-12-01

Liquid animal hoof conditioner

#23506
20050266101
2005-12-01

Natural sedative composition, process for obtaining the same and pharmaceutical formulations thereof

#23507
20050266098
2005-12-01

Composition for treatment of a hydrofluoric acid burn

#23508
20050266096
2005-12-01

New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits

#23509
20050266094
2005-12-01

Topical composition and method for the treatment and prophylaxis of dermal irritations

#23510
20050266089
2005-12-01

Contact lens and eye drop rewetter compositions and methods

#23511
20050266081
2005-12-01

Antimicrobial silver hydrogels

#23512
20050266076
2005-12-01

Resorbable delivery systems for the treatment of cancer

#23513
20050266064
2005-12-01

Cosmetic compositions and methods

#23514
20050266061
2005-12-01

Transdermal delivery of cannabidiol

#23515
20050266051
2005-12-01

Pet food compositions and methods

#23516
20050266050
2005-12-01

Antimicrobial composition and method for use

#23517
20050266035
2005-12-01

Skin protectant spray compositions

#23518
20050266032
2005-12-01

Dosage form containing multiple drugs

#23519
20050266024
2005-12-01

Adjuvant

#23520
20050266018
2005-12-01

Nutraceutical compositions with mangosteen

#23521
20050266006
2005-12-01

Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors

#23522
20050265973
2005-12-01

Chimeric adenoviruses for use in cancer treatment

#23523
20050265966
2005-12-01

Methods of treating cancer using IL-21 and monoclonal antibody therapy

#23524
20050265965
2005-12-01

Modified cytokines for use in cancer therapy

#23525
20050265963
2005-12-01

Immunodynamic complexes and methods for using and preparing such complexes

#23526
20050265954
2005-12-01

Novel association, a method of its preparation and its uses

#23527
20050265953
2005-12-01

Method of obtaining phytoalexins

#23528
20050265932
2005-12-01

Collagenolytic active enzyme containing compositions, and their use in the dental field

#23529
20050265930
2005-12-01

Physiological cooling compositions

#23530
20050261584
2005-11-24

Devices and methodologies useful in body aesthetics

#23531
20050261377
2005-11-24

Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction

#23532
20050261369
2005-11-24

Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor

#23533
20050261362
2005-11-24

Method of increasing endogenous adiponectin and leptin production

#23534
20050261349
2005-11-24

Medicine for prevention or treatment of diabetes

#23535
20050261344
2005-11-24

Treatment of lower urinary tract symptoms associated with overactive bladder in men and women

#23536
20050261328
2005-11-24

Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents

#23537
20050261310
2005-11-24

Piperazinylpiperidine derivatives as chemokine receptor antagonists

#23538
20050261293
2005-11-24

Compounds which inhibit leukocyte adhesion mediated by VLA-4

#23539
20050261287
2005-11-24

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

#23540
20050261283
2005-11-24

Methods and compositions for the treatment of graft failure

#23541
20050261282
2005-11-24

Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines

#23542
20050261280
2005-11-24

Stabilized antihistamine syrup

#23543
20050261278
2005-11-24

Selective serotonin receptor inverse agonists as therapeutics for disease

#23544
20050261275
2005-11-24

Therapeutic combination

#23545
20050261267
2005-11-24

Pharmaceutical formulation

#23546
20050261260
2005-11-24

Combination of a CDK inhibitor and mitoxantrone

#23547
20050261257
2005-11-24

Compositions for treating or preventing cardiovascular disease

#23548
20050261250
2005-11-24

Compositions and methods for inhibiting bone resorption

#23549
20050261243
2005-11-24

Antiprostaglandins for the treatment of ocular pathologies

#23550
20050261241
2005-11-24

Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses

#23551
20050261240
2005-11-24

Carrageenan based antimicrobial compositions

#23552
20050261224
2005-11-24

Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function

#23553
20050261220
2005-11-24

Tumor treating combinations, compositions and methods

#23554
20050261213
2005-11-24

Nucleic acid compositions and methods for use

#23555
20050261208
2005-11-24

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease

#23556
20050261202
2005-11-24

Sensitization to another anticancer therapy and/or amelioration of a side effect of another anitcancer therapy by treatment with a GST-activated anticancer compound

#23557
20050261197
2005-11-24

Coffee bean extract, method of extraction and composition containing the same

#23558
20050261191
2005-11-24

NGAL for reduction and amelioration of ischemic and nephrotoxic injuries

#23559
20050261186
2005-11-24

Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2

#23560
20050261182
2005-11-24

Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin

#23561
20050261178
2005-11-24

Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas

#23562
20050261171
2005-11-24

Combination cancer therapy

#23563
20050261170
2005-11-24

Folate conjugates and complexes

#23564
20050261167
2005-11-24

Compositions for sleeping disorders

#23565
20050261165
2005-11-24

Methods of reducing microbial resistance to drugs

#23566
20050260601
2005-11-24

Recombinant mutants of rhabdovirus and methods of use thereof

#23567
20050260292
2005-11-24

Method for extraction lectin from , medical composition for inhibiting tumor growth, biological reagent for detecting glycophorin A on blood and blood typing kit

#23568
20050260291
2005-11-24

Methods and compositions for reactivating acetylcholinesterase

#23569
20050260290
2005-11-24

Botanical anti-inflammatory compositions and methods

#23570
20050260289
2005-11-24

Therapeutic lotion for dermatitis

#23571
20050260288
2005-11-24

Treating cancer, liver, kidney, platelet and hemopoietic disorder or complication

#23572
20050260287
2005-11-24

Natural hormone replacement therapy

#23573
20050260286
2005-11-24

Intensive anti-cellulite formula

#23574
20050260285
2005-11-24

Healthy prostate formula

#23575
20050260283
2005-11-24

Composition for prevention and treatment of colon adenomas

#23576
20050260280
2005-11-24

Contact lens and eye drop rewetter compositions and methods

#23577
20050260277
2005-11-24

Method and formula for anti-tumor and anti-matastatic effect

#23578
20050260269
2005-11-24

Composition containing nano-crystalline apatite

#23579
20050260262
2005-11-24

Dosage forms of bisphosphonates

#23580
20050260258
2005-11-24

Use of vitelline protein B as a microencapsulating additive

#23581
20050260210
2005-11-24

Use of anti-α5β1 antibodies to inhibit cancer cell proliferation

#23582
20050260208
2005-11-24

Binding agents and their use in targeting tumor cells

#23583
20050260206
2005-11-24

Drugs containing genetically modified antibody against ganglioside gd3

#23584
20050260195
2005-11-24

Treatment of hepatitis B virus infection with human monoclonal antibodies

#23585
20050260186
2005-11-24

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#23586
20050260181
2005-11-24

Compositions and methods for tissue repair

#23587
20050260162
2005-11-24

Conditionally replicative adenovirus to target the Rb and Rb-related pathways

#23588
20050260156
2005-11-24

Modified vaccinia virus ankara for the vaccination of neonates

#23589
20050260155
2005-11-24

Compositions and methods for treatment of ulcerative colitis

#23590
20050260152
2005-11-24

Hair growth composition

#23591
20050260140
2005-11-24

Mucolytic and anti-elastase compounds and methods of use thereof

#23592
20050260139
2005-11-24

Pharmaceutical compositions based on anticholinergics and CCR2 receptor antagonists

#23593
20050256194
2005-11-17

Denaturants for sympathomimetic amine salts

#23594
20050256193
2005-11-17

Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity

#23595
20050256192
2005-11-17

Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual

#23596
20050256187
2005-11-17

Method and composition for synergistic topical therapy for neuromuscular pains

#23597
20050256186
2005-11-17

Prevention of and countermeasures against mitochondrial disease

#23598
20050256183
2005-11-17

HSP90-inhibiting zearalanol compounds and methods of producing and using same

#23599
20050256178
2005-11-17

Novel nutraceutical compositions comprising boitin

#23600
20050256175
2005-11-17

Novel glucagon antagonists/inverse agonists

#23601
20050256149
2005-11-17

Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts

#23602
20050256146
2005-11-17

Alpha-7 nicotinic receptor agonists and stains in combination

#23603
20050256141
2005-11-17

Remedies for glomerular diseases

#23604
20050256128
2005-11-17

Antimycobacterial pharmaceutical composition

#23605
20050256123
2005-11-17

Heterocyclic inhibitors of MEK and methods of use thereof

#23606
20050256095
2005-11-17

Asthma and colitis treatment methods

#23607
20050256093
2005-11-17

Branched polyamine steroid derivatives

#23608
20050256088
2005-11-17

Pharmaceutical nitrones

#23609
20050256086
2005-11-17

Fosinopril formulation

#23610
20050256083
2005-11-17

Preserved pharmaceutical compositions comprising cyclodextrins

#23611
20050256081
2005-11-17

Tetracycline derivatives for the treatment of ocular pathologies

#23612
20050256070
2005-11-17

Adjuvant

#23613
20050256059
2005-11-17

Methods and compositions for treatment of neurological disorder

#23614
20050256054
2005-11-17

Drug therapy for celiac sprue

#23615
20050256053
2005-11-17

Combined use of a GLP-1 compound and another drug for treating dyslipidemia

#23616
20050256048
2005-11-17

Selective androgen receptor modulators and methods for their identification, design and use

#23617
20050256046
2005-11-17

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

#23618
20050256031
2005-11-17

Composition for relieving discomfort

#23619
20050255180
2005-11-17

Prevention of diabetes by medicinal plants & fruits

#23620
20050255179
2005-11-17

Food supplement

#23621
20050255178
2005-11-17

Enhancing the effectiveness of an inhaled therapeutic gas

#23622
20050255173
2005-11-17

Anticancer composition

#23623
20050255169
2005-11-17

Adjuvant containing xenon

#23624
20050255168
2005-11-17

Cerebral protection with a gas comprising xenon

#23625
20050255167
2005-11-17

Medicinal Agent for Preventing and Treating Endocrine System Disturbances

#23626
20050255166
2005-11-17

Therapeutic composition comprising honey or a honey derivative

#23627
20050255162
2005-11-17

Hydrophobic biomolecular structure

#23628
20050255151
2005-11-17

Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds

#23629
20050255132
2005-11-17

Softening cream

#23630
20050255122
2005-11-17

Prevention and treatment of amyloidogenic disease

#23631
20050255119
2005-11-17

1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives

#23632
20050255112
2005-11-17

Compositions and methods for preventing erythropoietin-associated hypertension

#23633
20050255110
2005-11-17

Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies

#23634
20050255108
2005-11-17

Co-administration of a thrombolytic and an-anti-CD18 antibody in stroke

#23635
20050255106
2005-11-17

Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40

#23636
20050255100
2005-11-17

Methods of treatment with TNFR5

#23637
20050255096
2005-11-17

Combination treatment for acute myocardial infarction

#23638
20050255092
2005-11-17

Method and composition for reducing disease and enhancing performance

#23639
20050255085
2005-11-17

Prevention of recurrence and metastasis of cancer

#23640
20050255076
2005-11-17

Therapeutic cream for dermatitis

#23641
20050255071
2005-11-17

Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors

#23642
20050255065
2005-11-17

Aluminium and hexamethylenetetramine complex and the applications thereof

#23643
20050255060
2005-11-17

Personal care compositions and methods regulating mammalian hair growth

#23644
20050255059
2005-11-17

Personal care compositions and methods regulating mammalian hair growth

#23645
20050255049
2005-11-17

Formoterol and mometasone aerosol formulations

#23646
20050255048
2005-11-17

Sprayable formulations for the treatment of acute inflammatory skin conditions

#23647
20050255038
2005-11-17

Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof

#23648
20050250950
2005-11-10

1,3-oxathiolane nucleoside analogues

#23649
20050250854
2005-11-10

Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents

#23650
20050250852
2005-11-10

Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate

#23651
20050250851
2005-11-10

Methods for treating neuropsychiatric disorders

#23652
20050250850
2005-11-10

Amino acid composition promoting collagen synthesis

#23653
20050250843
2005-11-10

Medicinal compositions improving brain function and method for improving brain function

#23654
20050250840
2005-11-10

Mycophenolate mofetil in diabetic nephropathy

#23655
20050250817
2005-11-10

Pharmaceutical compositions of lipase-containing products, in particular of pancreation

#23656
20050250803
2005-11-10

Combination of dopamine agonists and monoamine reuptake inhibitors

#23657
20050250801
2005-11-10

Method of treating cancer with azaspirane compositions

#23658
20050250757
2005-11-10

Use of targeted oxidative therapeutic formulation in treatment of cancer

#23659
20050250756
2005-11-10

Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration

#23660
20050250755
2005-11-10

Use of targeted oxidative therapeutic formulation in bone regeneration

#23661
20050250748
2005-11-10

Combination therapy of angiotensin converting enzyme inhibitor and eplerenone for treatment of cardiovascular disease

#23662
20050250747
2005-11-10

Management of breakthrough bleeding in extended hormonal contraceptive regimens

#23663
20050250746
2005-11-10

Premenstrual dysphoric disorder medication

#23664
20050250734
2005-11-10

Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels

#23665
20050250726
2005-11-10

Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases

#23666
20050250715
2005-11-10

Remedy

#23667
20050250710
2005-11-10

Antiaging composition

#23668
20050250709
2005-11-10

Anti-neoplastic agents, combination therapies and related methods

#23669
20050250703
2005-11-10

Antioxidant constituents

#23670
20050250701
2005-11-10

Method of treating the syndrome of coronary heart disease risk factors in humans

#23671
20050250695
2005-11-10

Combination PDGF, KGF, IGF, and IGFBP for wound healing

#23672
20050250692
2005-11-10

Compositions and methods for inhibiting cell proliferation

#23673
20050250691
2005-11-10

Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes

#23674
20050250682
2005-11-10

Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions

#23675
20050250672
2005-11-10

Preparation for the prophylaxis of restenosis

#23676
20050249838
2005-11-10

Use of fermented wheat-germ in the feeding and veterinary practice

#23677
20050249827
2005-11-10

Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite

#23678
20050249826
2005-11-10

Orally administrabel composition for improving skin quality

#23679
20050249823
2005-11-10

Methods for the prevention or amelioration of neuropsychiatric and related diseases

#23680
20050249821
2005-11-10

Nutritional supplement for treatment of ocular diseases

#23681
20050249818
2005-11-10

Polycationic antimicrobial therapeutic

#23682
20050249814
2005-11-10

Solubility of hydrophobic drugs with a compound having a carboxylic acid moiety

#23683
20050249809
2005-11-10

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

#23684
20050249806
2005-11-10

Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug

#23685
20050249804
2005-11-10

Stabilized short-course chemotherapy (SCC) anti-tuberculosis drug compositions

#23686
20050249795
2005-11-10

Gemcitabine compositions for better drug delivery

#23687
20050249793
2005-11-10

Athletic patch

#23688
20050249788
2005-11-10

Methods and compositions for reducing oxidative stress in an animal

#23689
20050249787
2005-11-10

Methods and compositions for reducing oxidative stress in an animal

#23690
20050249768
2005-11-10

Environmentally safe insect repellent composition

#23691
20050249761
2005-11-10

Topical composition comprising at least one aryl oxime and bisabolol

#23692
20050249760
2005-11-10

Human body affinitive lubricating protective and repair gel

#23693
20050249728
2005-11-10

Anti-IGF-I receptor antibody

#23694
20050249727
2005-11-10

Prevention and treatment of amyloidogenic disease

#23695
20050249725
2005-11-10

Humanized antibodies that recognize beta amyloid peptide

#23696
20050249720
2005-11-10

Cosmetic skin formulation

#23697
20050249717
2005-11-10

Use of hyaluronidase for preventing and treating cardio vascular diseases

#23698
20050249712
2005-11-10

Methods for use of TSLP and agonists and antagonists thereof

#23699
20050249710
2005-11-10

Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use

#23700
20050249708
2005-11-10

Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells